betsat bettilt vegabet betkanyon matbet celtabet hilbet melbet kingbetting wipbet pusulabet superbahis lidyabet holiganbet 1xbet asyabahis jetbahis betdoksan betetebet betgram
Adrian Lescano1 Author
Subjects of specialization
Affiliation
Total knee Arthroplasty, Hemostasis
Department of cardiology, Trinidad Quilmes, Argentina
physician at New York University School of Medicine. He is trained as a pulmonary critical care physician. He is board certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine. He currently works in the Bellevue Medical Intensive Care Unit and has special interests in Ultrasound, Special Pathogens and house staff education.
Research Article Open Access
Author(s): Adrian Lescano1,2*,
Background: Pulmonary Arterial Hypertension (PAH) is a chronic and progressive disease characterized by an increase in the pulmonary pressure and pulmonary vascular resistance that leads to high morbidity and mortality. Macitentan is an endothelin receptor antagonist (ERA), that has shown benefit in terms of morbidity and mortality (as a composite endpoint) in a randomized controlled trial (SERAPHIN), but information regarding the use of this drug in the daily clinical practice is limited in our region. Objective: To describe clinical outcomes in patients with a diagnosis of Pulmonary Hypertension (PH) treated with Macitentan in Argentina. Methods: Retrospective, observational study including adult patients with a diagnosis of PH, confirmed by right heart catheterization, who were treat... view moreĀ»